Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
Authors
Keywords
Breast cancer biomarker assays, STRAT4, Estrogen receptor, Progesterone receptor, Human epidermal growth factor receptor 2, Tumor proliferation rate, IHC, FISH
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-17
DOI
10.1007/s10549-018-4889-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer
- (2017) Hope S. Rugo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence
- (2017) Brad E Wasserman et al. LABORATORY INVESTIGATION
- Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa
- (2017) Cynthia Pomaa Akuoko et al. PLoS One
- Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines forHER2Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice
- (2016) Michael F. Press et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- A clinician’s guide to biosimilars in oncology
- (2016) Hope S. Rugo et al. CANCER TREATMENT REVIEWS
- HER2Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
- (2016) Michael F. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis
- (2016) Elima Jedy-Agba et al. Lancet Global Health
- Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab
- (2016) Sherene Loi et al. JAMA Oncology
- Strategies for developing Ki67 as a useful biomarker in breast cancer
- (2015) Carsten Denkert et al. BREAST
- Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2015) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- Molecular markers for breast cancer diagnosis, prognosis and targeted therapy
- (2014) Julie E. Lang et al. JOURNAL OF SURGICAL ONCOLOGY
- Breast Cancer--Thinking Globally
- (2014) B. O. Anderson SCIENCE
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31
- (2013) Katherine L. Pogue-Geile et al. JNCI-Journal of the National Cancer Institute
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer
- (2011) Chungyeul Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started